Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Exploring the relationship between Alzheimer's disease severity and longitudinal costs.

Rapp T, Andrieu S, Molinier L, Grand A, Cantet C, Mullins CD, Vellas B.

Value Health. 2012 May;15(3):412-9. doi: 10.1016/j.jval.2012.02.003. Epub 2012 Apr 10.

PMID:
22583450
[PubMed - indexed for MEDLINE]
2.

Determinants of costs of care for patients with Alzheimer's disease.

Jönsson L, Eriksdotter Jönhagen M, Kilander L, Soininen H, Hallikainen M, Waldemar G, Nygaard H, Andreasen N, Winblad B, Wimo A.

Int J Geriatr Psychiatry. 2006 May;21(5):449-59.

PMID:
16676288
[PubMed - indexed for MEDLINE]
3.

Patients with Alzheimer's disease living at home in France: costs and consequences of the disease.

Rigaud AS, Fagnani F, Bayle C, Latour F, Traykov L, Forette F.

J Geriatr Psychiatry Neurol. 2003 Sep;16(3):140-5.

PMID:
12967055
[PubMed - indexed for MEDLINE]
4.

The cost of dementia in Europe: a review of the evidence, and methodological considerations.

Jönsson L, Wimo A.

Pharmacoeconomics. 2009;27(5):391-403. doi: 10.2165/00019053-200927050-00004. Review.

PMID:
19586077
[PubMed - indexed for MEDLINE]
5.

The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings.

Wimo A, Reed CC, Dodel R, Belger M, Jones RW, Happich M, Argimon JM, Bruno G, Novick D, Vellas B, Haro JM.

J Alzheimers Dis. 2013;36(2):385-99. doi: 10.3233/JAD-122392.

PMID:
23629588
[PubMed - indexed for MEDLINE]
6.

Predictors of costs of care in Alzheimer's disease: a multinational sample of 1222 patients.

Gustavsson A, Brinck P, Bergvall N, Kolasa K, Wimo A, Winblad B, Jönsson L.

Alzheimers Dement. 2011 May;7(3):318-27. doi: 10.1016/j.jalz.2010.09.001.

PMID:
21575872
[PubMed - indexed for MEDLINE]
7.

Clinical characteristics and longitudinal changes of informal cost of Alzheimer's disease in the community.

Zhu CW, Scarmeas N, Torgan R, Albert M, Brandt J, Blacker D, Sano M, Stern Y.

J Am Geriatr Soc. 2006 Oct;54(10):1596-602.

PMID:
17038080
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease.

Wimo A, Winblad B, Stöffler A, Wirth Y, Möbius HJ.

Pharmacoeconomics. 2003;21(5):327-40.

PMID:
12627986
[PubMed - indexed for MEDLINE]
9.

Costs of care in a mild-to-moderate Alzheimer clinical trial sample: key resources and their determinants.

Gustavsson A, Cattelin F, Jönsson L.

Alzheimers Dement. 2011 Jul;7(4):466-73. doi: 10.1016/j.jalz.2010.06.002.

PMID:
21784355
[PubMed - indexed for MEDLINE]
10.

Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settings.

Reese JP, Hessmann P, Seeberg G, Henkel D, Hirzmann P, Rieke J, Baum E, Dannhoff F, Müller MJ, Jessen F, Geldsetzer MB, Dodel R.

J Alzheimers Dis. 2011;27(4):723-36. doi: 10.3233/JAD-2011-110539.

PMID:
21876256
[PubMed - indexed for MEDLINE]
11.

Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina.

Allegri RF, Butman J, Arizaga RL, Machnicki G, Serrano C, Taragano FE, Sarasola D, Lon L.

Int Psychogeriatr. 2007 Aug;19(4):705-18. Epub 2006 Jul 27.

PMID:
16870037
[PubMed - indexed for MEDLINE]
13.

Economic impact of Alzheimer's disease in the United Kingdom. Cost of care and disease severity for non-institutionalised patients with Alzheimer's disease.

Souêtre E, Thwaites RM, Yeardley HL.

Br J Psychiatry. 1999 Jan;174:51-5.

PMID:
10211151
[PubMed - indexed for MEDLINE]
14.

The cost of Alzheimer's disease in managed care: a cross-sectional study.

Leon J, Neumann PJ.

Am J Manag Care. 1999 Jul;5(7):867-77.

PMID:
10557408
[PubMed - indexed for MEDLINE]
Free Article
15.

A dependency model for patients with Alzheimer's disease: its validation and relationship to the costs of care--the LASER-AD Study.

Livingston G, Katona C, Roch B, Guilhaume C, Rive B.

Curr Med Res Opin. 2004 Jul;20(7):1007-16.

PMID:
15265245
[PubMed - indexed for MEDLINE]
16.

Economic analysis of Alzheimer's disease in outpatients: impact of symptom severity.

Souêtre EJ, Qing W, Vigoureux I, Dartigues JF, Lozet H, Lacomblez L, Derouesné C.

Int Psychogeriatr. 1995 Spring;7(1):115-22.

PMID:
7579015
[PubMed - indexed for MEDLINE]
17.

Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.

Lopez-Bastida J, Serrano-Aguilar P, Perestelo-Perez L, Oliva-Moreno J.

Neurology. 2006 Dec 26;67(12):2186-91.

PMID:
17190942
[PubMed - indexed for MEDLINE]
18.

Cost effectiveness of donepezil in the treatment of mild to moderate Alzheimer's disease: a UK evaluation using discrete-event simulation.

Getsios D, Blume S, Ishak KJ, Maclaine GD.

Pharmacoeconomics. 2010;28(5):411-27. doi: 10.2165/11531870-000000000-00000.

PMID:
20402542
[PubMed - indexed for MEDLINE]
19.

The impact of parkinsonism on costs of care in patients with AD and dementia with Lewy bodies.

Murman DL, Kuo SB, Powell MC, Colenda CC.

Neurology. 2003 Oct 14;61(7):944-9.

PMID:
14557565
[PubMed - indexed for MEDLINE]
20.

Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease.

Zhu CW, Scarmeas N, Torgan R, Albert M, Brandt J, Blacker D, Sano M, Stern Y.

Neurology. 2006 Sep 26;67(6):998-1005. Epub 2006 Aug 16.

PMID:
16914696
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk